ACTIVE

Apotheek Wijgmaal Brug

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result118,8 k €+19,9 %over 1 year
Gross margin166,8 k €+29,2 %over 1 year
Equity309,4 k €+23,5 %over 1 year

Identity

Source · BCE/KBO

Apotheek Wijgmaal Brug is a Public limited company incorporated in 1996. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Leuven.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0457.651.542
Incorporation
29/03/1996
Legal form
Public limited company
Registered office
Vaartdijk 11 box 1
3018 Leuven · FlandreSee on map
Contributed capital
61 973,38 €
Latest accounts
31/12/2024
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20242023202220212020
Income statement
Gross margin166,8 k €129,1 k €167,1 k €189,7 k €106,4 k €
EBITDA166,1 k €127,6 k €166,6 k €182,4 k €98,8 k €
Operating result143,4 k €103,8 k €142,7 k €157,3 k €73,9 k €
Net result118,8 k €99,1 k €143,2 k €158,1 k €75,7 k €
Balance sheet
Equity309,4 k €250,5 k €250,4 k €250,2 k €249,1 k €
Total assets665,7 k €638,1 k €662,9 k €703,1 k €568,2 k €
Cash45,2 k €62,6 k €35,1 k €7,9 k €19,8 k €
Debts356,3 k €387,1 k €411,9 k €452,7 k €316,3 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 21 ended

Active mandates

Katleen Quisthoudt

Director

Active
Leuven Pharma Services

Director · 0643.870.855

Represented by Kristien Doms

Active

Ended mandates

Katleen Quisthoudt

Director · since 26 novembre 2023

Ended
Leuven Pharma Services

Director · since 26 novembre 2023 · 0643.870.855

Represented by Kristien DOMS

Ended
Jan Quisthoudt

Director · since 01 janvier 2016 · until 31 décembre 2021

Ended
Katleen Quisthoudt

Director · since 01 janvier 2016 · until 31 décembre 2021

Ended

Other companies at this address

Vaartdijk 11 3018 Leuven
CompanyCBE no.
Apotheek Wijgmaal Dorp● Active
0449.259.854
Beheer Van Den Borre● Active
0477.372.533
Leuven Pharma Services● Active
0643.870.855
Pardimmo● Active
0400.644.642
Vereniging van mede-eigenaars Residentie Wijchmael te 3018 Herent (Wijgmaal) , Vaartdijk 11 (voorheen 7)● Active
0824.219.193
Wipoli● Active
0738.938.377

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/08/202526/08/202427/07/202327/06/202226/08/202130/08/2020
General meeting05/06/202506/06/202401/06/202302/06/202203/06/202104/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202405/06/202531/08/2025DutchPDF
Abridged model31/12/202306/06/202426/08/2024DutchPDF
Abridged model31/12/202201/06/202327/07/2023DutchPDF
Abridged model31/12/202102/06/202227/06/2022DutchPDF
Abridged model31/12/202003/06/202126/08/2021DutchPDF
Abridged model31/12/201904/06/202030/08/2020DutchPDF
Abridged model31/12/201806/06/201907/06/2019DutchPDF
Abridged model31/12/201707/06/201817/07/2018DutchPDF
Abridged model31/12/201601/06/201726/07/2017DutchPDF
Abridged model31/12/201502/06/201626/08/2016DutchPDF
Abridged model31/12/201404/06/201528/08/2015DutchPDF
Abridged model31/12/201305/06/201426/08/2014DutchPDF
Abridged model31/12/201207/06/201327/08/2013DutchPDF
Abridged model31/12/201107/06/201229/06/2012DutchPDF
Abridged model31/12/201003/06/201112/08/2011DutchPDF
Abridged model31/12/200903/06/201011/06/2010DutchPDF
Abridged model31/12/200825/06/200914/07/2009DutchPDF
Abridged model31/12/200705/06/200823/06/2008DutchPDF
Abridged model31/12/200607/06/200730/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 21 ended

Active mandates

Katleen Quisthoudt

Director

Active
Leuven Pharma Services

Director · 0643.870.855

Represented by Kristien Doms

Active

Ended mandates

Katleen Quisthoudt

Director · since 26 novembre 2023

Ended
Leuven Pharma Services

Director · since 26 novembre 2023 · 0643.870.855

Represented by Kristien DOMS

Ended
Jan Quisthoudt

Director · since 01 janvier 2016 · until 31 décembre 2021

Ended
Katleen Quisthoudt

Director · since 01 janvier 2016 · until 31 décembre 2021

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/11/2023
    ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Registered office26/08/2019
    BENAMING - MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates25/06/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/09/2016
    ONTSLAGEN - BENOEMINGEN - DIVERSEN
    PDF
  • Mandates28/01/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/07/2008
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares14/12/2005
    KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024118,8 k €↑
  2. 2023
    Annual accounts 202399,1 k €↓
  3. 2022
    Annual accounts 2022143,2 k €↓
  4. 2021
    Annual accounts 2021158,1 k €↑
  5. 2020
    Annual accounts 202075,7 k €↑
  6. 2019
    Annual accounts 201940,8 k €↓
  7. 2018
    Annual accounts 201857,3 k €↑
  8. 2017
    Annual accounts 201740 k €↓
  9. 2016
    Annual accounts 201667,4 k €↑
  10. 2015
    Annual accounts 201540,8 k €↑
  11. 2014
    Annual accounts 2014-2,1 k €↓
  12. 2013
    Annual accounts 201315,4 k €↓
  13. 2012
    Annual accounts 201217,2 k €↑
  14. 2011
    Annual accounts 20111,1 k €↓
  15. 2010
    Annual accounts 201044,9 k €↑
  16. 2009
    Annual accounts 2009-37 k €↑
  17. 2008
    Annual accounts 2008-88,2 k €↓
  18. 2007
    Annual accounts 200729,1 k €↑
  19. 2006
    Annual accounts 200613,1 k €
  20. 29/03/1996
    IncorporationPublic limited company